These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 4053794)

  • 1. [Myelodysplastic syndrome: analysis of 17 cases].
    Zhu P; Mu LP; Ma LF
    Zhonghua Nei Ke Za Zhi; 1985 May; 24(5):280-3, 318. PubMed ID: 4053794
    [No Abstract]   [Full Text] [Related]  

  • 2. [Myelodysplastic syndrome classified based on FAB proposals: analysis of 58 cases].
    Li TY; Gong SH; Zhao SR
    Zhonghua Nei Ke Za Zhi; 1985 Apr; 24(4):217-20, 255. PubMed ID: 4006614
    [No Abstract]   [Full Text] [Related]  

  • 3. [Panmyelopathy and myeloproliferative syndrome].
    Jorke D; Bach G
    Z Gesamte Inn Med; 1986 Nov; 41(21):595-8. PubMed ID: 3469815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The characteristics of the pre- and leukemic stages of chronic myeloproliferative diseases in persons suffering as a result of the Chernobyl catastrophe].
    Klimenko VI; Pilinskaia MA; Cherviakova EV; Liubarets TF
    Lik Sprava; 2000; (1):13-7. PubMed ID: 10878966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [An analysis on 56 cases of preleukemia (author's transl)].
    Zhonghua Nei Ke Za Zhi; 1982 Jan; 21(1):8-10. PubMed ID: 7075371
    [No Abstract]   [Full Text] [Related]  

  • 6. Studies on blood and bone marrow findings of myelodysplastic syndromes: evaluation of proposals for classification of myelodysplastic syndromes.
    Yang CL; Li LQ; Chen WJ; Yang TY; Sun YM; Li XY
    Proc Chin Acad Med Sci Peking Union Med Coll; 1988; 3(1):7-11. PubMed ID: 3174618
    [No Abstract]   [Full Text] [Related]  

  • 7. [How to assess a bone-marrow oligoblastosis in apparently normal subjects or those without a definite proliferative hemopathy].
    Woessner S; Sans-Sabrafen J; Lafuente R; Florensa L
    Sangre (Barc); 1984; 29(2):164-73. PubMed ID: 6382648
    [No Abstract]   [Full Text] [Related]  

  • 8. Partial myeloperoxidase deficiency.
    Cech P; Schneider P; Bachmann F
    Acta Haematol; 1982; 67(3):180-4. PubMed ID: 6282028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rheumatic manifestations in patients with myelodysplastic and myeloproliferative diseases.
    Kuzmich PV; Ecker GA; Karsh J
    J Rheumatol; 1994 Sep; 21(9):1649-54. PubMed ID: 7799343
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Preleukemic states].
    Vacarezza R
    Rev Med Chil; 1982 Jul; 110(7):679-86. PubMed ID: 6296959
    [No Abstract]   [Full Text] [Related]  

  • 11. Auer rod positive dysmyelopoietic syndrome.
    Weisdorf DJ; Oken MM; Johnson GJ; Rydell RE
    Am J Hematol; 1981 Dec; 11(4):397-402. PubMed ID: 6949477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Critical study of the concept of the myeloproliferative syndrome (author's transl)].
    Najean Y
    Nouv Presse Med; 1977 Oct; 6(35):3179-83. PubMed ID: 270652
    [No Abstract]   [Full Text] [Related]  

  • 13. [Diagnostic difficulties in osteomyelosclerosis with myeloid metaplasia in relation to the other components of the myeloproliferative syndrome].
    Vilcu A; Hossu T; Popescu ID; Câmpeanu L
    Med Interna (Bucur); 1973 Mar; 25(3):363-76. PubMed ID: 4527026
    [No Abstract]   [Full Text] [Related]  

  • 14. [Role of hemopoietic stem cells and progenitor cells in preleukemia].
    Dörmer P; Mergenthaler HG
    Verh Dtsch Ges Pathol; 1990; 74():65-74. PubMed ID: 1708637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Treatment of myelodysplastic syndromes].
    Aul C; Heyll A; Gattermann N; Schneider W
    Dtsch Med Wochenschr; 1987 Feb; 112(8):309-13. PubMed ID: 3469067
    [No Abstract]   [Full Text] [Related]  

  • 16. Myeloproliferative syndromes. Current opinions from the European Hematology Association Working Group on Myeloproliferative Disorders.
    Brière J
    Pathol Biol (Paris); 2001 Mar; 49(2):138-9. PubMed ID: 11317958
    [No Abstract]   [Full Text] [Related]  

  • 17. Bone marrow mast cell morphologic features and hematopoietic dyspoiesis in systemic mast cell disease.
    Stevens EC; Rosenthal NS
    Am J Clin Pathol; 2001 Aug; 116(2):177-82. PubMed ID: 11488063
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The preleukemic syndrome. Dysplasia hemopoietica].
    Majolino I; Panizza P; Nalli G; Trpin L; Barosi G; Ascari E
    Recenti Prog Med; 1978 Apr; 64(4):404-45. PubMed ID: 356143
    [No Abstract]   [Full Text] [Related]  

  • 19. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders.
    Del Cañizo MC; Brufau A; Mota A; Lopez N; Fernandez ME; Vallejo C; Hernandez JM; Garcia JL; San Miguel JF
    Haematologica; 1998 Jan; 83(1):3-7. PubMed ID: 9580461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases.
    Orazi A
    Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.